<div id="readability-page-1"><div> <div> , /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde &amp; Associates PC (the &#34;M&amp;A Class Action Firm&#34;), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating <ul type="disc"> <li>VYNE Therapeutics Inc. (NASDAQ: VYNE) related to its merger with Yarrow Bioscience, Inc. Upon completion of the proposed transaction, VYNE shareholders are expected to own 3% of the combined company.</li> </ul> Click here for more information https://monteverdelaw.com/case/vyne-therapeutics-inc/. It is free and there is no cost or obligation to you. <ul type="disc"> <li>Masimo Corporation (NASDAQ: MASI) related to its sale to Danaher Corporation. Under the terms of the proposed transaction, Masimo shareholders will receive $180.00 per share in cash.</li> </ul> ACT NOW. The Shareholder Vote is scheduled for May 1, 2026. Click here for more information https://monteverdelaw.com/case/masimo-corporation/. It is free and there is no cost or obligation to you. <ul type="disc"> <li>Independent Bank Corporation (NASDAQ: IBCP) related to its sale to HCB Financial Corp. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.</li> </ul> Click here for more information https://monteverdelaw.com/case/independent-bank-corporation/. It is free and there is no cost or obligation to you. <ul type="disc"> <li>HCB Financial Corp. (OTCPK: HCBN) related to its merger with Independent Bank Corporation. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.</li> </ul> Click here for more info https://monteverdelaw.com/case/hcb-financial-corp/. It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask: <ol type="1"> <li>Do you file class actions and go to Court?</li> <li>When was the last time you recovered money for shareholders?</li> <li>What cases did you recover money in and how much?</li> </ol> About Monteverde &amp; Associates PC Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE &amp; ASSOCIATES PC The Empire State Building 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America [email protected] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde &amp; Associates PC. The law firm responsible for this advertisement is Monteverde &amp; Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde &amp; Associates PC <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDAxJk5ld3NJdGVtSWQ9REMyNTAwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDExNDA2UFJfTkVXU19VU1BSX19fX19EQzI1MDA4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDAxJk5ld3NJdGVtSWQ9REMyNTAwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDExNDA2UFJfTkVXU19VU1BSX19fX19EQzI1MDA4"/></div> </div></div>

ARWR

Class Action Attorney Juan Monteverde is investigating mergers involving VYNE Therapeutics, Masimo Corporation, Independent Bank Corporation, and HCB Financial Corp. VYNE shareholders will own 3% of the merged entity with Yarrow Bioscience. Masimo shareholders will receive $180 per share from Danaher Corporation. HCB shareholders will get 1.5900 shares of Independent stock and $17.51 per HCB share. The shareholder vote for Masimo is set for May 1, 2026. Monteverde & Associates PC has a strong track record in recovering funds for shareholders.

prnewswire

SPDR S&P Health Equip

iShares Global Healthcare

ArrowHead Pharma

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

Ark Genomic Revolution ETF

Masimo

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

ALPS Medical Breakthrough

iShares US Medical Devices

14:06 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN